Anju Starace

599 total citations
8 papers, 462 citations indexed

About

Anju Starace is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Anju Starace has authored 8 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 3 papers in Pediatrics, Perinatology and Child Health and 1 paper in Pharmacology. Recurrent topics in Anju Starace's work include Bipolar Disorder and Treatment (7 papers), Schizophrenia research and treatment (6 papers) and Epilepsy research and treatment (2 papers). Anju Starace is often cited by papers focused on Bipolar Disorder and Treatment (7 papers), Schizophrenia research and treatment (6 papers) and Epilepsy research and treatment (2 papers). Anju Starace collaborates with scholars based in Hungary, United States and India. Anju Starace's co-authors include I. Laszlovszky, György Németh, Suresh Durgam, Adam Ruth, Raffaele Migliore, Kaifeng Lu, Dayong Li, Roy H. Perlis, Joseph R. Calabrese and Paul E. Keck and has published in prestigious journals such as Journal of Affective Disorders, Schizophrenia Research and The Journal of Clinical Psychiatry.

In The Last Decade

Anju Starace

8 papers receiving 458 citations

Peers

Anju Starace

PMH

CMN

PHARM

CP

MB

Raffaele Migliore United States

Hitomi Akazawa Japan

M. Debelle Hungary

Juan Schronen South Africa

Pedro Such Denmark

Christian Geretsegger Austria

Joseph Pultz United States

C. A. Gagiano South Africa

B. Szatmári Hungary

Jay Hsu United States

Raffaele Migliore United States

Anju Starace

473 ×1.2

PMH

132 ×1.3

CMN

112 ×1.3

PHARM

87 ×1.8

CP

42 ×1.0

MB

Citations per year, relative to Anju Starace Anju Starace (= 1×) peers Raffaele Migliore

Countries citing papers authored by Anju Starace

Since Specialization

Citations

This map shows the geographic impact of Anju Starace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anju Starace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anju Starace more than expected).

Fields of papers citing papers by Anju Starace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anju Starace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anju Starace. The network helps show where Anju Starace may publish in the future.

Co-authorship network of co-authors of Anju Starace

This figure shows the co-authorship network connecting the top 25 collaborators of Anju Starace. A scholar is included among the top collaborators of Anju Starace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anju Starace. Anju Starace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Ketter, Terence A., Roy H. Perlis, Suresh Durgam, et al.. (2017). The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study. Journal of Affective Disorders. 225. 350–356. 29 indexed citations

2.

Durgam, Suresh, Anju Starace, Dayong Li, et al.. (2014). An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial. Schizophrenia Research. 152(2-3). 450–457. 147 indexed citations

3.

Perlis, Roy H., William M. Greenberg, Anju Starace, et al.. (2014). Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial. Journal of Affective Disorders. 174. 296–302. 90 indexed citations

4.

Durgam, Suresh, Anju Starace, Raffaele Migliore, et al.. (2014). The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. Bipolar Disorders. 17(1). 63–75. 96 indexed citations

5.

Calabrese, Joseph R., Paul E. Keck, Anju Starace, et al.. (2014). Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder. The Journal of Clinical Psychiatry. 76(3). 284–292. 95 indexed citations

6.

Ketter, T A, G S Sachs, Kaifeng Lu, et al.. (2013). P.2.d.024 Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder. European Neuropsychopharmacology. 23. S377–S377. 1 indexed citations

7.

Calabrese, J.R., P E Keck, Anju Starace, et al.. (2013). P.2.d.026 Efficacy and safety of low- and high-dose cariprazine in patients with acute mania associated with bipolar I disorder. European Neuropsychopharmacology. 23. S378–S379. 1 indexed citations

8.

Starace, Anju, Esperanza Díaz, Jack M. Goodman, et al.. (2012). P.2.e.016 Cariprazine in the treatment of acute mania in bipolar disorder: a double-blind, placebo-controlled, phase III trial. European Neuropsychopharmacology. 22. S285–S285. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact